Immunodiagnostic Systems Share Discussion Threads

[wjccghcc] 23/1/2012 09:17

Yup. PBT now approx 20% below forecasts for the full year.

[aleks_atanasov] 23/1/2012 08:52

today's RNS sounds like a profit warning

[spacecake] 23/1/2012 08:33

What happened today !! - from £12 to >£3 in the space of a few months.

[philo124] 22/1/2012 19:57

What happened on Friday??

[praipus] 16/12/2011 12:00

Hi IDH BB,

Newton Investment Management like IDH collecting 5.35%!

For anyone who likes to follow deep value/activist investors I'm tracking their holdings in post 9 on the WAM thread:

[alftupper] 06/12/2011 19:13

yes but it depends upon their largest shareholder Forum Group and also Dr Duggan

[spacecake] 05/12/2011 16:48

Could they attract a bid at these levels ?

[dasv] 02/12/2011 09:59

agree with you there silverfern. Lucky for me I got out at 1200p. phew

[silverfern] 29/11/2011 22:45

alf, no Dave Evans knows exactly what he is doing. I mean, job done, the new set of skills needed when a company needs to get into a market through innovation and acquisition is different from the set that keeps them there. REplacing the one with the other is not easy. IDH shares have been hit but it's their fault- they give scant info in their RNS's in the good times and enjoyed 1000% share price rises in two years so if the Board have options and shares its now for them to decide to 'fess up in a mature way or take the AIM way and restrict info and wing it. WOrks on the way up but it really doesn't if you stall

[alftupper] 29/11/2011 19:37

I agree they should have updated the market further once Diasorin had updated the market - look at the difference in price reaction between the two. What do you mean beware of departing Chairmen - did he leave under a cloud ?

[silverfern] 29/11/2011 13:16

what would gall me if I was still holding would be the October trading update- all calm and serene. The current price may reflect the lack of Director buying, and the risk that they are losing the competitive battle. ALso beware departing Chairmen. THe price may never get back to 1200p and it now needs a new range of management skills to keep market share and justify a 600-800p trading range.

[alftupper] 29/11/2011 06:13

The market reaction is completely overdone but that's what you get when numbers are missed - a bit of a shambles really as this could have been communicated at the same time as Diasorin their largest competitor realigned their forecasts - why did it take IDH six weeks longer to inform the market - this has lost nearly 60% since the summer high.

[longshanks] 29/11/2011 06:00

Wow £100m wiped off the market cap for underperforming by less than £1m on the unaudited 6 months results.

Could be further pain to come but this is now much more attractive as an investment. Will be watching this for signs of a recovery....

[spacecake] 28/11/2011 20:37

FT Small Caps

Immunodiagnostic Systems , which makes medical diagnostic products, slumped 40 per cent to 471¼p after weaker half-year results than expected prompted broker downgrades.

Investec said the company's profit before tax, at £7.7m, was 10 per cent below its forecast.

"Whilst we believe IDH has a competitive offering and the ability to grow at double-digit rates in the short term, the earnings miss is disappointing and we move back to a hold," it said.

[spacecake] 28/11/2011 16:41

Collins Stewart downgrades Immunodiagnostic Systems from buy to hold, target price cut from 939p to 789p.

[pugugly] 28/11/2011 16:12

Market now seems to be rating as ex growth and seeing as how brewin are the house broker in my opinion one should probaly guess that their forcasts are are "rose tinted glasses" type and probably need to be discounted - The increase in competion could be a killer - Lower turnover but still the same overheads and a reduced margin.

Not nice - could well imo have further to fall. Now 16:08 28/11/11 at 433/455

[alftupper] 28/11/2011 15:42

crazy 42% drop - this remains a growth story.

[mw16] 28/11/2011 15:25

Overreaction in my book. Below 10 pe. Still a growth share.

[alftupper] 28/11/2011 15:03

This is a bloodbath - there seems to be no floor

[freshvoice] 28/11/2011 14:32

mw16
Interesting. More buys than sells. Price dropped by 160p before a trade was even made.

Late sales now showing

[philo124] 28/11/2011 13:18

CS ditto but lower eps forecasts.

[spacecake] 28/11/2011 12:00

Analysts at Brewin Dolphin downgraded their forecasts following the results from pre-tax profits of £20.6 million (EPS: 56.6p) to £18 million (EPS: 47.5p) for the year to March 2012. In 2013 profits were downgraded from £24.5 million (EPS: 67.2p) to £20 million (EPS: 51.2p)

[mw16] 28/11/2011 11:01

Interesting. More buys than sells. Price dropped by 160p before a trade was even made.

How does this make sense?